ObjectiveThis study aimed to investigate the anti-Mycoplasma pneumoniae (MP) activity of luteolin and elucidate its underlying mechanisms. MethodsLuteolin was identified as the primary active compound from the polyphenol extract ofF. diotrys using network pharmacology. Its efficacy was evaluated against two MP strains: the standard strain M129 and the multidrug-resistant strain M19. A modified culture medium with visual characteristics was employed to determine the minimum inhibitory concentration (MIC) of luteolin. The expression of key proteins involved in MP growth and pathogenicity was assessed by qRT-PCR following luteolin treatment. Additionally, the viability of A549 cells infected with MP was compared between luteolin-treated and untreated groups. In vivo anti-MP activity was evaluated using a mouse model, and the expression of inflammatory cytokines in lung tissues was analyzed. ResultsLuteolin effectively inhibited both MP strains, with MIC₉₀ values of 100 mg/L for M19 and M129. Treatment with luteolin significantly downregulated the expression of adhesion proteins P1 and P30 in both strains. However, the expression of P65, HMW3, TrmB, and CARDS TX was reduced only in the M19 strain following luteolin intervention. Luteolin also enhanced the growth and viability of A549 cells infected with MP. In the mouse model, luteolin treatment resulted in steady weight gain and was well tolerated. The bacteriostatic rate of luteolin in lung tissues was 50.7%, significantly higher than the 25.2% observed in the roxithromycin group. Furthermore, luteolin reduced the expression of inflammatory factors, including IL-6, TNF-α, and HMGB1, in MP-infected mice. ConclusionLuteolin effectively and safely inhibits the proliferation and pathogenicity of MP, particularly the drug-resistant M19 strain, by downregulating the expression of toxicity-associated proteins (P1, P30, P65, HMW3, TrmB, CARDS TX) and modulating host inflammatory responses. These findings suggest that luteolin may offer a novel therapeutic strategy for treating MP infections, especially those caused by drug-resistant strains.

ObjectiveThis study aimed to investigate the anti-Mycoplasma pneumoniae (MP) activity of luteolin and elucidate its underlying mechanisms. MethodsLuteolin was identified as the primary active compound from the polyphenol extract ofF. diotrys using network pharmacology. Its efficacy was evaluated against two MP strains: the standard strain M129 and the multidrug-resistant strain M19. A modified culture medium with visual characteristics was employed to determine the minimum inhibitory concentration (MIC) of luteolin. The expression of key proteins involved in MP growth and pathogenicity was assessed by qRT-PCR following luteolin treatment. Additionally, the viability of A549 cells infected with MP was compared between luteolin-treated and untreated groups. In vivo anti-MP activity was evaluated using a mouse model, and the expression of inflammatory cytokines in lung tissues was analyzed. ResultsLuteolin effectively inhibited both MP strains, with MIC₉₀ values of 100 mg/L for M19 and M129. Treatment with luteolin significantly downregulated the expression of adhesion proteins P1 and P30 in both strains. However, the expression of P65, HMW3, TrmB, and CARDS TX was reduced only in the M19 strain following luteolin intervention. Luteolin also enhanced the growth and viability of A549 cells infected with MP. In the mouse model, luteolin treatment resulted in steady weight gain and was well tolerated. The bacteriostatic rate of luteolin in lung tissues was 50.7%, significantly higher than the 25.2% observed in the roxithromycin group. Furthermore, luteolin reduced the expression of inflammatory factors, including IL-6, TNF-α, and HMGB1, in MP-infected mice. ConclusionLuteolin effectively and safely inhibits the proliferation and pathogenicity of MP, particularly the drug-resistant M19 strain, by downregulating the expression of toxicity-associated proteins (P1, P30, P65, HMW3, TrmB, CARDS TX) and modulating host inflammatory responses. These findings suggest that luteolin may offer a novel therapeutic strategy for treating MP infections, especially those caused by drug-resistant strains.

The objective assessment of hearing loss is one of the critical components in forensic clini-cal research.Auditory brainstem response(ABR)is an important method for objectively assessing hearing levels.It is divided into various types based on different stimulus signals,each with its own characteris-tics and applications.Among them,narrow-band Chirp ABR,due to its frequency specificity,fulfills the basic requirements for objective assessment of forensic audiology,promising to be an important method of objective hearing assessment in forensic medicine.This article reviews the development history,charac-teristics and clinical applications of Chirp ABR,and envisions its application prospects in forensic audi-tory identification.

Taking Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine as an example,this paper sum-marizes the important role and practical experience of new cultural development in promoting the hospital's high-quality growth.It explores pathways for new cultural development to facilitate the high-quality advancement of integrated traditional Chinese and Western medicine hospitals,aiming to provide valuable practical guidance and theoretical support for such hospitals in the context of the new era.

Wastewater-based epidemiology has emerged as a transformative surveillance tool for estimating substance consumption and monitoring disease prevalence, particularly during the COVID-19 pandemic. It enables the population-level monitoring of illicit drug use, pathogen prevalence, and environmental pollutant exposure. In this perspective, we summarize the key challenges specific to the Chinese context: (1) Sampling inconsistencies, necessitating standardized 24-hour composite protocols with high-frequency autosamplers (≤ 15 min/event) to improve the representativeness of samples; (2) Biomarker validation, requiring rigorous assessment of excretion profiles and in-sewer stability; (3) Analytical method disparities, demanding inter-laboratory proficiency testing and the development of automated pretreatment instruments; (4) Catchment population dynamics, reducing estimation uncertainties through mobile phone data, flow-based models, or hydrochemical parameters; and (5) Ethical and data management concerns, including privacy risks for small communities, mitigated through data de-identification and tiered reporting platforms. To address these challenges, we propose an integrated framework that features adaptive sampling networks, multi-scale wastewater sample banks, biomarker databases with multidimensional metadata, and intelligent data dashboards. In summary, wastewater-based epidemiology offers unparalleled scalability for equitable health surveillance and can improve the health of the entire population by providing timely and objective information to guide the development of targeted policies.
China/epidemiology* ; Humans ; Wastewater/analysis* ; COVID-19/epidemiology* ; Public Health ; Wastewater-Based Epidemiological Monitoring ; SARS-CoV-2

Human Respiratory Stem Cells (RSCs) play a crucial role in the maintenance, repair and regeneration of the respiratory system. As a novel therapeutic method, stem cell therapy is a popular research direction in the medical field. And with the in-depth research on the mechanism of pneumonia caused by respiratory infections in recent years, the use of RSCs to explore pneumonia caused by respiratory infections and its therapeutic strategies has become a hot topic. In this paper, we firstly outlined the types of RSCs, summarized the mechanism of pneumonia caused by respiratory tract infections, discussed the advantages of RSCs application and the progress of culture differentiation, and elaborated the therapeutic exploration of RSCs in pneumonia caused by respiratory tract infections.

[Objective]To explore the application characteristics of medication"Atractylodes Rhizome"in Synopsis of Golden Chamber and summarize clinical approaches to syndrome differentiation and treatment.[Methods]ZHANG Zhongjing's experience in using Atractylodes Rhizome was comprehensively analyzed from source,dosage,compatibility characteristics,etc.[Results]Synopsis of Golden Chamber mentions a total of 24 applications of Atractylodes Rhizome for treating different diseases.Its main therapeutic effects are to tonify Qi and invigorate the spleen,tonify deficiency and relieve obstruction,dry dampness and diuresis,stabilize the fetus and consolidate the foundation.Although the text does not explicitly differentiate between Atractylodes ovata and Atractylodes sinensis,but it suggests Atractylodes ovata is more important in tonifying Qi,invigorating the spleen,stopping sweat and calming the fetus,while Atractylodes sinensis is better in dispelling wind and cold,drying dampness and invigorating the spleen.Both have their own strengths in formula compatibility,and the differences in dosage and dosage forms are closely related to their therapeutic effects.[Conclusion]Zhongjing was good at treating diseases according to syndrome differentiation,not limited to one prescription,one method and one path.He cleverly utilized the characteristics of Atractylodes Rhizome,flexibly selected dosage forms and adjusted dosage,and adjusted drug combinations according to disease symptoms.The formula he produced not only can enter the middle-Jiao to strengthen the spleen and promote diuresis,but also can enter the superficial tissues to dispel wind and dampness.It can also enter the Chongren to replenish Qi and prevent miscarriage,as well as tonify deficiency and eliminate painful impediment syndrome,which had great guiding significance for clinical application.

Taking Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine as an example,this paper sum-marizes the important role and practical experience of new cultural development in promoting the hospital's high-quality growth.It explores pathways for new cultural development to facilitate the high-quality advancement of integrated traditional Chinese and Western medicine hospitals,aiming to provide valuable practical guidance and theoretical support for such hospitals in the context of the new era.

[Objective]To explore the application characteristics of medication"Atractylodes Rhizome"in Synopsis of Golden Chamber and summarize clinical approaches to syndrome differentiation and treatment.[Methods]ZHANG Zhongjing's experience in using Atractylodes Rhizome was comprehensively analyzed from source,dosage,compatibility characteristics,etc.[Results]Synopsis of Golden Chamber mentions a total of 24 applications of Atractylodes Rhizome for treating different diseases.Its main therapeutic effects are to tonify Qi and invigorate the spleen,tonify deficiency and relieve obstruction,dry dampness and diuresis,stabilize the fetus and consolidate the foundation.Although the text does not explicitly differentiate between Atractylodes ovata and Atractylodes sinensis,but it suggests Atractylodes ovata is more important in tonifying Qi,invigorating the spleen,stopping sweat and calming the fetus,while Atractylodes sinensis is better in dispelling wind and cold,drying dampness and invigorating the spleen.Both have their own strengths in formula compatibility,and the differences in dosage and dosage forms are closely related to their therapeutic effects.[Conclusion]Zhongjing was good at treating diseases according to syndrome differentiation,not limited to one prescription,one method and one path.He cleverly utilized the characteristics of Atractylodes Rhizome,flexibly selected dosage forms and adjusted dosage,and adjusted drug combinations according to disease symptoms.The formula he produced not only can enter the middle-Jiao to strengthen the spleen and promote diuresis,but also can enter the superficial tissues to dispel wind and dampness.It can also enter the Chongren to replenish Qi and prevent miscarriage,as well as tonify deficiency and eliminate painful impediment syndrome,which had great guiding significance for clinical application.